In the BioHarmony Drug Report Database

"Preview" Icon

Dienogest

Natazia (dienogest) is a small molecule pharmaceutical. Dienogest was first approved as Natazia on 2010-05-06. It is used to treat endometriosis in the USA. Natazia’s patents are valid until 2028-01-30 (FDA).

 

Trade Name

 

Natazia
 

Common Name

 

dienogest
 

ChEMBL ID

 

CHEMBL1201864
 

Indication

 

endometriosis
 

Drug Class

 

Progestogen; Progestin; Steroidal antiandrogen

Image (chem structure or protein)

Dienogest structure rendering